HB 5494 – Rhode Island

Status: Inactive / Dead
Year Introduced: 2021
Link: http://webserver.rilin.state.ri.us/BillText/BillText21/HouseText21/H5494.pdf

AN ACT RELATING TO BUSINESSES AND PROFESSIONS — DRUG COST TRANSPARENCY: Provides drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers to the director of the department of business regulation regarding drug prices and increases the prices.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found